Free Trial

CorVel (CRVL) Competitors

CorVel logo
$74.11 -0.50 (-0.67%)
Closing price 04:00 PM Eastern
Extended Trading
$74.10 -0.01 (-0.01%)
As of 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CRVL vs. DVA, CHE, MD, AMN, CCRN, LH, DGX, APG, ULS, and RTO

Should you be buying CorVel stock or one of its competitors? The main competitors of CorVel include DaVita (DVA), Chemed (CHE), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), APi Group (APG), UL Solutions (ULS), and Rentokil Initial (RTO).

CorVel vs. Its Competitors

CorVel (NASDAQ:CRVL) and DaVita (NYSE:DVA) are both mid-cap health care services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

In the previous week, DaVita had 3 more articles in the media than CorVel. MarketBeat recorded 5 mentions for DaVita and 2 mentions for CorVel. DaVita's average media sentiment score of 1.29 beat CorVel's score of -0.27 indicating that DaVita is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CorVel
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
DaVita
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CorVel has a net margin of 10.98% compared to DaVita's net margin of 6.35%. DaVita's return on equity of 369.39% beat CorVel's return on equity.

Company Net Margins Return on Equity Return on Assets
CorVel10.98% 32.31% 18.33%
DaVita 6.35%369.39%4.62%

DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CorVel$895.59M4.25$95.17M$1.9438.20
DaVita$13.16B0.71$936.34M$10.1712.89

51.4% of CorVel shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 44.6% of CorVel shares are held by company insiders. Comparatively, 1.5% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

DaVita has a consensus price target of $158.00, suggesting a potential upside of 20.53%. Given DaVita's higher possible upside, analysts plainly believe DaVita is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CorVel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
DaVita
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80

CorVel has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, DaVita has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500.

Summary

DaVita beats CorVel on 9 of the 15 factors compared between the two stocks.

Get CorVel News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRVL vs. The Competition

MetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ Exchange
Market Cap$3.80B$5.70B$35.54B$10.53B
Dividend YieldN/A3.70%2.84%4.67%
P/E Ratio38.2027.2126.5026.92
Price / Sales4.251.791,133.47184.15
Price / Cash30.4115.4328.6531.10
Price / Book11.824.548.336.71
Net Income$95.17M$156.97M$197.16M$276.35M
7 Day Performance-4.28%-1.36%2.52%3.10%
1 Month Performance-13.30%-3.58%13.68%10.19%
1 Year Performance-28.17%54.07%84.02%40.37%

CorVel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRVL
CorVel
1.2596 of 5 stars
$74.11
-0.7%
N/A-29.3%$3.80B$895.59M38.205,075Analyst Downgrade
DVA
DaVita
4.7516 of 5 stars
$130.66
-0.1%
$158.00
+20.9%
-20.2%$9.35B$12.82B12.8576,000Positive News
CHE
Chemed
5 of 5 stars
$452.36
-2.1%
$578.50
+27.9%
-25.2%$6.74B$2.51B23.2615,695
MD
Pediatrix Medical Group
1.7597 of 5 stars
$16.21
-0.5%
$16.79
+3.5%
+45.4%$1.42B$2.01B12.574,305News Coverage
Analyst Upgrade
AMN
AMN Healthcare Services
4.2962 of 5 stars
$18.51
-1.9%
$23.25
+25.6%
-48.3%$723.17M$2.77B-2.382,968Positive News
CCRN
Cross Country Healthcare
3.3364 of 5 stars
$13.76
-3.3%
$17.93
+30.3%
+8.7%$466.20M$1.19B-52.928,205
LH
Labcorp
4.7788 of 5 stars
$282.65
+0.7%
$290.33
+2.7%
+27.4%$23.32B$13.01B31.2070,000
DGX
Quest Diagnostics
4.7545 of 5 stars
$188.83
-0.1%
$186.00
-1.5%
+18.4%$21.13B$9.87B22.6156,000Positive News
APG
APi Group
3.1031 of 5 stars
$34.28
+0.2%
$36.10
+5.3%
+63.4%$14.23B$7.02B107.1229,000Positive News
Short Interest ↑
ULS
UL Solutions
1.3723 of 5 stars
$70.18
+1.1%
$70.86
+1.0%
+45.7%$13.95B$2.87B43.3215,094Positive News
RTO
Rentokil Initial
1.6372 of 5 stars
$24.65
-0.2%
N/A+9.2%$12.48B$6.92B16.3368,485News Coverage
Analyst Upgrade
Gap Up

Related Companies and Tools


This page (NASDAQ:CRVL) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners